CIK 0001348362 · Non-accelerated filer<br>Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 202000871
- Phone
- 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | Baxter Nicholas W Director | Other disposition · Stock Options | −5,000 | 1,500 | ||
| 2021-05-07 | Carle Vanessa Secretary | Other disposition · Stock Options | −5,000 | 12,567 | ||
| 2021-04-26 | McKechnie William Edward Director | Grant or award · Stock Options | +1,500 | 6,500 | ||
| 2021-04-26 | Downey Gregory Chief Financial Officer | Grant or award · Stock Options | +5,000 | 25,000 | ||
| 2021-04-26 | BUNKA CHRISTOPHER CEO | Grant or award · Stock Options | +26,000 | 56,001 | ||
| 2021-04-26 | DOCHERTY JOHN MARTIN President | Grant or award · Stock Options | +18,000 | 49,668 | ||
| 2021-04-26 | Baxter Nicholas W Director | Grant or award · Stock Options | +1,500 | 6,500 | ||
| 2021-04-26 | Carle Vanessa Secretary | Grant or award · Stock Options | +12,500 | 17,567 | ||
| 2021-02-01 | REESE ALBERT L JR Director | Grant or award · Stock Options | +3,400 | 3,400 | ||
| 2020-11-10 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | $0.20 | $2K | 6,445,844 |
| 2020-11-10 | BUNKA CHRISTOPHER CEO | Purchase | +6,000 | $0.20 | $1K | 6,451,844 |
| 2020-11-10 | BUNKA CHRISTOPHER CEO | Purchase | +25,500 | $0.19 | $5K | 6,477,344 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +37,500 | $0.22 | $8K | 6,379,344 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | $0.20 | $2K | 6,389,344 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +10,000 | $0.21 | $2K | 6,399,344 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +8,000 | $0.20 | $2K | 6,407,344 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +6,500 | $0.20 | $1K | 6,413,844 |
| 2020-11-09 | BUNKA CHRISTOPHER CEO | Purchase | +22,000 | $0.20 | $4K | 6,435,844 |
| 2020-11-06 | BUNKA CHRISTOPHER CEO | Purchase | +60,000 | $0.21 | $12K | 6,341,844 |
| 2020-07-23 | McKechnie William Edward Director | Option exercise | +110,000 | $0.17 | $19K | 395,738 |
Page 5 of 6 · 118 trades